Polyarteritis nodosa type vasculitis in a patient with familial Mediterranean fever treated with cyclosporin A

Patients with amyloidosis secondary to familial Mediterranean fever (FMF) are known to tolerate cyclosporin A poorly. We report a case of severe cyclosporin toxicity in a patient with FMF amyloidosis who underwent kidney transplantation. The clinical syndrome consisted of severe gastrointestinal, neuromuscular, and psychiatric disturbances. Histological examination of the transplanted kidney revealed vasculitis of the polyarteritis nodosa type. We hypothesize that FMF patients are more vulnerable to the acute vascular toxicity of cyclosporin due to defective inhibition of complement activation, leading to a widespread vasculitis of the polyarteritis nodosa type.

[1]  A. Yussim,et al.  Renal transplantation in patients with amyloidosis due to familial Mediterranean fever. , 1992, Transplantation proceedings.

[2]  J. Light,et al.  Colchicine-induced myoneuropathy in a renal transplant patient. , 1992, Transplantation.

[3]  M. Tarawneh,et al.  Spectrum of renal involvement in familial Mediterranean fever. , 1992, Kidney international.

[4]  A. Schattner,et al.  A proposed mechanism of the inflammatory attacks in familial Mediterranean fever. , 1992, Archives of internal medicine.

[5]  A. Hartmann,et al.  Fifteen years' experience with renal transplantation in systemic amyloidosis , 1992, Transplant international : official journal of the European Society for Organ Transplantation.

[6]  A. Bakkaloğlu,et al.  Familial Mediterranean fever and polyarteritis nodosa. , 1992, Scandinavian journal of rheumatology.

[7]  D. Zemer,et al.  Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever. , 1992, Nephron.

[8]  J. Feehally,et al.  Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  F. Laurencet,et al.  [Periodic disease and periarteritis nodosa in the same patient: coincidence?]. , 1991, Swiss medical weekly.

[10]  J. Donadio,et al.  De novo systemic vasculitis in a renal transplant recipient. , 1991, Mayo Clinic proceedings.

[11]  M. Pras,et al.  Tumor necrosis factor in familial Mediterranean fever. , 1991, The American journal of medicine.

[12]  Z. Ackerman,et al.  Proposed mechanism of the inflammatory attacks in familial Mediterranean fever. , 1990, Archives of internal medicine.

[13]  S. Ayesh,et al.  Partial characterization of a C5a-inhibitor in peritoneal fluid. , 1990, Journal of immunology.

[14]  G. Neild.  Cyclosporin nephrotoxicity. , 1990, Seminars in thoracic and cardiovascular surgery.

[15]  P. Chassagne,et al.  MYOPATHY AS POSSIBLE SIDE-EFFECT OF CYCLOSPORIN , 1989, The Lancet.

[16]  M. El-Khateeb,et al.  Rapid progressive glomerulonephritis in patients with familial Mediterranean fever. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  S. Oren,et al.  Perirenal and renal subcapsular haematoma as presenting symptoms of polyarteritis nodosa. , 1989, Postgraduate medical journal.

[18]  J. Stauffer,et al.  MYOPATHY AS POSSIBLE SIDE-EFFECT OF CYCLOSPORIN , 1989, The Lancet.

[19]  M. Glikson,et al.  Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature. , 1989, The Journal of rheumatology.

[20]  K. Salmela,et al.  Renal transplantation in amyloidosis. , 1989, Transplantation proceedings.

[21]  Lie Jt.  Systemic and isolated vasculitis. A rational approach to classification and pathologic diagnosis. , 1989 .

[22]  G. Boner,et al.  Cyclosporin: poorly tolerated in familial Mediterranean fever. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  J. Lie.  Systemic and isolated vasculitis. A rational approach to classification and pathologic diagnosis. , 1989, Pathology annual.

[24]  M. Noppen,et al.  Cyclosporine and myopathy. , 1987, Annals of internal medicine.

[25]  K. Isono,et al.  Histopathologic studies in renal transplant recipient dogs receiving treatment with FK-506. , 1987, Transplantation Proceedings.

[26]  V. Mazzaferro,et al.  Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. , 1987, Transplantation proceedings.

[27]  M. Rogawski,et al.  Colchicine myopathy and neuropathy. , 1987, The New England journal of medicine.

[28]  D. Zemer,et al.  Cyclosporine toxicity in amyloidotic patients. , 1987, Transplantation proceedings.

[29]  J. Ahonen,et al.  RENAL TRANSPLANTATION IN 45 PATIENTS WITH AMYLOIDOSIS , 1986, Transplantation.

[30]  Cook Gc.  Periodic disease, recurrent polyserositis, familial Mediterranean fever, or simply 'FMF'. , 1986 .

[31]  F. Fenech,et al.  Familial Mediterranean fever (recurrent hereditary polyserositis) in Arabs--a study of 175 patients and review of the literature. , 1986, The Quarterly journal of medicine.

[32]  D. Zemer,et al.  Cyclosporine and familial Mediterranean fever amyloidosis. , 1986, Transplantation.

[33]  G. Cook.  Periodic disease, recurrent polyserositis, familial Mediterranean fever, or simply 'FMF'. , 1986, The Quarterly journal of medicine.

[34]  A. Rubinow,et al.  Henoch-Schönlein purpura and familial Mediterranean fever. , 1985, Israel journal of medical sciences.

[35]  Y. Matzner,et al.  C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. , 1984, The New England journal of medicine.

[36]  D. Schiller,et al.  Schönlein-Henoch syndrome in patients with familial Mediterranean fever. , 1982, Arthritis and rheumatism.

[37]  D. Ilstrup,et al.  Clinical features, prognosis, and response to treatment in polyarteritis. , 1980, Mayo Clinic proceedings.

[38]  E. Jacob,et al.  Renal transplantation in the amyloidosis of familial Mediterranean fever. Experience in ten cases. , 1979, Archives of internal medicine.